Australia Scraps Experimental Coronavirus Vaccine Candidate After Trial Participants Receive False Positive Results On Certain HIV Tests
Sydney Morning Herald: Australian COVID vaccine terminated due to HIV ‘false positives’
“A billion-dollar deal for the Morrison government to buy more than 50 million doses of the University of Queensland’s potential coronavirus vaccine has been abruptly terminated after several trial participants returned false positive HIV test results…” (Harris, 12/11).
Wall Street Journal: Covid-19 Vaccine Candidate Scrapped After False Positives on HIV Tests
“A Covid-19 vaccine candidate in Australia has been scrapped because recipients returned false positives on certain HIV tests, underscoring the difficulties scientists face in rapidly developing an inoculation for the coronavirus. The vaccine candidate, called v451, was being jointly developed by the University of Queensland and CSL Ltd., an Australia-based biopharma company that also runs blood-collection centers in the U.S. The Australian government had agreed to buy 51 million doses…” (Cherney, 12/10).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.